Verily
North America, California, United States, South San Francisco
Description
Verily is an Alphabet health tech company focused on research, care, and health financing to deliver on the promise of precision health.
Investor Profile
Verily has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 6% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series A (31%)
- Series B (25%)
- Series Unknown (19%)
- Seed (13%)
- Post Ipo Equity (6%)
- Series C (6%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Health Diagnostics
- Cloud Data Services
- Industrial Automation
- Robotics
- Software
- Life Science
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
